InvestorsHub Logo
Followers 22
Posts 888
Boards Moderated 0
Alias Born 05/09/2012

Re: farrell90 post# 350147

Wednesday, 03/03/2021 2:04:09 PM

Wednesday, March 03, 2021 2:04:09 PM

Post# of 403052
This PR is more relevant than ever now with the new strains circulating. Would like to hear more from the company about the Pan-Coronavirus strategy but assume that info will come after the Phase 2 results:

November 30, 2020 - Innovation Pharmaceuticals COVID-19 Clinical Trial to Support Additional Development of Brilacidin as a “Pan-Coronavirus” Therapeutic. Additional independent preliminary laboratory research suggests Brilacidin, the Company’s flagship defensin mimetic, can treat other endemic human coronaviruses (H-CoVs), such as those causing common colds, and not just SARS-CoV-2, the novel coronavirus responsible for the ongoing global COVID-19 pandemic.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News